Navarro-Santana B, Álvaro NM, Mayas-Flores A, Plaza-Arranz J

Language: Spanish
References: 14
Page: 401-405
PDF size: 307.55 Kb.

ABSTRACT

Background: Placental mesenchymal dysplasia is a rare disease of the placenta which presents with vesicles in the form of a cluster of grapes on ultrasound. It can cause pregnancy complications such as: intrauterine growth restriction, intrauterine death, and preterm birth
Clinical case: A 31-year-old patient with placental mesenchymal dysplacia diagnosed on the ultrasound of the first trimester of pregnancy, in which an area with 14 x 20 mm econegative formations was observed with little uptake of the color Doppler and which was confirmed in the second trimester by corial biopsy of that area. The pregnancy was normal until week 33, after which an intrauterine growth restriction was detected. Due to the high incidence of obstetric complications of this entity, an induction of labor was decided at week 37 of gestation.
Conclusions: Whenever this type of pathology is diagnosed, it is recommended a close follow-up of pregnancy and an induction of labor around 37-38 weeks of gestation, due to the perinatal complications presents.

REFERENCES

1. Moscoso G, Jauniaux E, Hustin J. Placental vascular anomaly with diffuse mesenchymal stem villous hyperplasia. A new clinico-pathological entity? Pathol Res Pract. 1991;187(2- 3):324-28.

2. Li H, Li L, Tang X, Yang F, Yang KX. Placental mesenchymal dysplasia: a case of a normal-appearing fetus with intrauterine growth restriction. Int J Clin Exp Pathol. 2014;7:5302-7.

3. Arizawa M, Nakayama M. Suspected involvement of the Xchromosome in placental mesenchymal dysplasia. Congenit Anom. 2002;42:309-17.

4. Nayeri UA, West AB, Grossetta NHK, Copel JA, Sfakianaki AK. Systematic review of sonographic findings of placental mesenchymal dysplasia and subsequent pregnancy outcome. Ultrasound Obstet Gynecol. 2013;41:366-74.

5. Chen CP, Chern SR, Wang TY, Huang ZD, Huang MC, Chuang CY. Pregnancy with concomitant chorangioma and placental vascular malformation with mesenchymal hyperplasia. HumReprod. 1997;12:2553-56.

6. Kaiser RKA, McFadden DE, Livasy CA, Dansereau J, et al. Androgenetic/biparental mosaicism causes placental mesenchymal dysplasia. J Med Genet. 2006;43:187-92.

7. Reed RC, Beischel L, Schoof J, Johnson J, Raff ML, Kapur RP. Androgenetic/biparental mosaicism in an infant with hepatic mesenchymal hamartoma and placental mesenchymal dysplasia. Pediatr Dev Pathol. 2008;11:377-83.

8. Martinez-Payo C, Bernabeu RA, Villar IS, Goy EI. Intrauterine growth restriction associated with hematologic abnormalities: Probable manifestations of placental mesenchymal dysplasia. AJP Reports. 2015;5:e085- e088.

9. Cohen MC, Roper EC, Sebire NJ, Stanek J, Anumba DOC. Placental mesenchymal dysplasia associated with fetal aneuploidy. Prenat Diagn. 2005;25:187-92.

10. Carta M, Maresi E, Giuffre M, Catalano G, et al. Congenital hepatic mesenchymal hamartoma associated with mesenchymal stem villous hyperplasia of the placenta: case report. J Pediatr Surg. 2005;40:E37-E39.

11. Koga H, Makimura M, Tanaka H, Sumioki H. Placental mesenchymal dysplasia and fetal hematologic disorder. J Pediatr Hematol Oncol. 2014;36:e389-e391.

12. Parveen Z, Tongson IJ, Fraser C, Killeen J, Thompson K. Placental mesenchymal dysplasia. Arch Pathol Lab Med. 2007;131:131-37.

13. Jalil SSA, Mahran MA, Sule M. Placental mesenchymal dysplasia - can it be predicted prenatally? A case report. Prenat Diagn. 2009;29:713-14.

14. Simeone S, Franchi C, Marchi L, Rambaldi MP, Serena C, Vitagliano A, Mecacci F. Management of placental mesenchymal dysplasia associated with fetal anemia and IUGR. Eur J Obstet Gynecol Reprod Biol. 2015 Jan;184:132-4.